IN-VITRO ACTIVITY OF 5 BETA-LACTAM/BETA-LACTAMASE INHIBITOR COMBINATIONS AGAINST CONSECUTIVE ISOLATES OF THE ENTEROBACTERIACEAE AND PSEUDOMONAS-AERUGINOSA

被引：10

作者：

MCLAUGHLIN, JC

BARRY, AL

FUCHS, PC

GERLACH, EH

HARDY, DJ

PFALLER, MA

机构：

[1] UNIV NEW MEXICO,MED CTR,ALBUQUERQUE,NM 87106

[2] CLIN MICROBIOL INST INC,TUALATIN,OR 97062

[3] ST VINCENT HOSP & MED CTR,PORTLAND,OR 97225

[4] ST FRANCIS REG MED CTR,WICHITA,KS 67214

[5] UNIV ROCHESTER,MED CTR,ROCHESTER,NY 14642

[6] OREGON HLTH SCI UNIV,PORTLAND,OR 97201

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1994年 / 33卷 / 02期

关键词：

D O I：

10.1093/jac/33.2.223

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Susceptibility tests were performed on 2402 of consecutive isolates of Enterobacteriaceae and 254 strains of Pseudomonas aeruginosa in five separate medical centres. Five β-lactams were evaluated with and without a β-lactamase inhibitor. The effect of different inhibitors was species specific and the rank order of decreasing efficacy against all enteric bacilli was: cefoperazone-sulbactam > piperacillin-tazobactam > cefoperazone > ticarcillin-clavulanic acid > piperacillin > co-amoxiclav > ampicillin-sulbactam > ticarcillin > ampicillin > amoxycillin. © 1994 The British Society for Antimicrobial Chemotherapy.

引用

收藏

页码：223 / 230

页数：8

相关论文

共 11 条

[1] TICARCILLIN AND TICARCILLIN-CLAVULANIC ACID SUSCEPTIBILITY TESTS - ERROR RATES FOR DISK TESTS WITH CONSECUTIVELY ISOLATED MEMBERS OF THE FAMILY ENTEROBACTERIACEAE [J].

BARRY, AL ;

FUCHS, PC ;

GERLACH, EH ;

HARDY, DJ ;

MCLAUGHLIN, JC ;

PFALLER, MA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) :137-143

[2]

Bryan LE, 1991, ANTIBIOTICS LABORATO, P599

[3] INVITRO ACTIVITY OF CEFOPERAZONE-SULBACTAM AGAINST BACTEROIDES SPECIES [J].

DIAS, MBS ;

JACOBUS, NV ;

TALLY, FP .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (04) :467-471

[4] COMPARATIVE-EVALUATION OF A NEW BETA-LACTAMASE INHIBITOR, YTR 830, COMBINED WITH DIFFERENT BETA-LACTAM ANTIBIOTICS AGAINST BACTERIA HARBORING KNOWN BETA-LACTAMASES [J].

GUTMANN, L ;

KITZIS, MD ;

YAMABE, S ;

ACAR, JF .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (05) :955-957

[5] COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR 830, CLAVULANATE, AND SULBACTAM COMBINED WITH AMPICILLIN AND BROAD-SPECTRUM PENICILLINS AGAINST DEFINED BETA-LACTAMASE-PRODUCING AEROBIC GRAM-NEGATIVE BACILLI [J].

JACOBS, MR ;

ARONOFF, SC ;

JOHENNING, S ;

SHLAES, DM ;

YAMABE, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (06) :980-985

[6] PIPERACILLIN TAZOBACTAM (YTR-830) COMBINATION - COMPARATIVE ANTIMICROBIAL ACTIVITY AGAINST 5889 RECENT AEROBIC CLINICAL ISOLATES AND 60 BACTEROIDES-FRAGILIS GROUP STRAINS [J].

JONES, RN ;

PFALLER, MA ;

FUCHS, PC ;

ALDRIDGE, K ;

ALLEN, SD ;

GERLACH, EH .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (06) :489-494

[7] STUDIES TO OPTIMIZE THE INVITRO TESTING OF PIPERACILLIN COMBINED WITH TAZOBACTAM (YTR-830) [J].

JONES, RN ;

BARRY, AL .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (06) :495-510

[8]

SYKES R B, 1976, Journal of Antimicrobial Chemotherapy, V2, P115, DOI 10.1093/jac/2.2.115

[9] SUSCEPTIBILITY OF TICARCILLIN-RESISTANT GRAM-NEGATIVE BACILLI TO DIFFERENT COMBINATIONS OF TICARCILLIN AND CLAVULANIC ACID [J].

VERBIST, L ;

VERHAEGEN, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 :7-15

[10]

1992, PERFORMANCE STANDARD